ATE234091T1 - Thrombin inhibitoren - Google Patents

Thrombin inhibitoren

Info

Publication number
ATE234091T1
ATE234091T1 AT97911748T AT97911748T ATE234091T1 AT E234091 T1 ATE234091 T1 AT E234091T1 AT 97911748 T AT97911748 T AT 97911748T AT 97911748 T AT97911748 T AT 97911748T AT E234091 T1 ATE234091 T1 AT E234091T1
Authority
AT
Austria
Prior art keywords
thrombin inhibitors
thrombin
inhibitors
compound
human thrombin
Prior art date
Application number
AT97911748T
Other languages
English (en)
Inventor
Craig Coburn
Christine Kolatac
Diane M Rush
Joseph P Vacca
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9624319.1A external-priority patent/GB9624319D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE234091T1 publication Critical patent/ATE234091T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT97911748T 1996-10-24 1997-10-20 Thrombin inhibitoren ATE234091T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2905396P 1996-10-24 1996-10-24
GBGB9624319.1A GB9624319D0 (en) 1996-11-22 1996-11-22 Thrombin inhibitors
PCT/US1997/018682 WO1998017274A1 (en) 1996-10-24 1997-10-20 Thrombin inhibitors

Publications (1)

Publication Number Publication Date
ATE234091T1 true ATE234091T1 (de) 2003-03-15

Family

ID=26310463

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97911748T ATE234091T1 (de) 1996-10-24 1997-10-20 Thrombin inhibitoren

Country Status (8)

Country Link
EP (1) EP0934064B1 (de)
JP (1) JP2001502691A (de)
AT (1) ATE234091T1 (de)
AU (1) AU715305B2 (de)
CA (1) CA2267260A1 (de)
DE (1) DE69719775T2 (de)
ES (1) ES2191830T3 (de)
WO (1) WO1998017274A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087373A (en) * 1997-09-23 2000-07-11 Merck & Co., Inc. Thrombin inhibitors
ES2209337T3 (es) * 1998-08-14 2004-06-16 Pfizer Inc. Agentes antitromboticos.
AU3127900A (en) 1998-12-23 2000-07-31 Du Pont Pharmaceuticals Company Thrombin or factor xa inhibitors
US6239132B1 (en) 1999-04-23 2001-05-29 Merck & Co., Inc. Thrombin inhibitors
US6458952B1 (en) 1999-05-19 2002-10-01 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
US6716838B1 (en) 1999-05-19 2004-04-06 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents
US6750342B1 (en) 1999-05-19 2004-06-15 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
US6653316B1 (en) 1999-05-19 2003-11-25 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
US6867217B1 (en) 1999-05-19 2005-03-15 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
US7015230B1 (en) 1999-05-19 2006-03-21 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
EP1189618A4 (de) * 1999-06-04 2002-06-19 Merck & Co Inc Thrombinhemmer
FR2795072B1 (fr) * 1999-06-15 2001-07-27 Adir Nouveaux derives bicycliques d'amino-pyrazinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6660885B2 (en) 2000-03-13 2003-12-09 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
PT1268463E (pt) 2000-04-05 2005-05-31 Pharmacia Corp 4-pironas substituidas com arilo e heteroarilo policiclicos uteis para a inibicao selectiva da cascata de coagulacao
US7119094B1 (en) 2000-11-20 2006-10-10 Warner-Lambert Company Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade
WO2002042272A2 (en) 2000-11-20 2002-05-30 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
US7015223B1 (en) 2000-11-20 2006-03-21 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade
FR2818277B1 (fr) * 2000-12-14 2003-01-24 Servier Lab Nouveaux derives bicycliques d'amino-pyrazinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1414449A4 (de) * 2001-05-22 2005-04-06 Bristol Myers Squibb Co Bizyklische faktor-xa-hemmer
EP1482940A2 (de) * 2001-10-03 2004-12-08 Pharmacia Corporation Prodrugs von substituierten polyzyclischen vebindungen für die selektive hemmung der koagulationskaskade
JP2005519866A (ja) 2001-10-03 2005-07-07 ファルマシア・コーポレーション 凝固カスケードの選択阻害に有用な６員複素環式化合物
EP1432687A2 (de) 2001-10-03 2004-06-30 Pharmacia Corporation Substitutierte fünfgliedrige polyzyclischen vebindungen für die selektive hemmung der koagulationskaskade
WO2009085472A1 (en) * 2007-12-19 2009-07-09 Elc Management Llc Compositions and methods for treating skin with extract from trametes
TWI903299B (zh) 2018-03-08 2025-11-01 美商英塞特公司 作為PI3K-γ抑制劑之胺基吡嗪二醇化合物
WO2020010003A1 (en) 2018-07-02 2020-01-09 Incyte Corporation AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0648780A1 (de) * 1993-08-26 1995-04-19 Bristol-Myers Squibb Company Heterozyklische Thrombinhemmer
AU703744B2 (en) * 1995-06-27 1999-04-01 Merck & Co., Inc. Pyridinone-thrombin inhibitors

Also Published As

Publication number Publication date
ES2191830T3 (es) 2003-09-16
DE69719775D1 (en) 2003-04-17
DE69719775T2 (de) 2004-02-05
CA2267260A1 (en) 1998-04-30
AU4905097A (en) 1998-05-15
EP0934064B1 (de) 2003-03-12
JP2001502691A (ja) 2001-02-27
EP0934064A1 (de) 1999-08-11
WO1998017274A1 (en) 1998-04-30
EP0934064A4 (de) 2002-01-09
AU715305B2 (en) 2000-01-20

Similar Documents

Publication Publication Date Title
ATE234091T1 (de) Thrombin inhibitoren
ATE209191T1 (de) Parazinon thrombin inhibitoren
NO973657D0 (no) Trombin-inhibitorer
ID18142A (id) Inhibitor metaloprotease 1,4-heterosiklik
ID18141A (id) Inhibitor metaloprotease 1,3-diheterosiklik
ATE264863T1 (de) 28-epirapaloge
PT936912E (pt) Inibidores de cisteina protease
ATE239755T1 (de) Thrombin inhibitoren
DE59711714D1 (de) Thrombininhibitoren
ID16104A (id) Inhibitor-inhibitor serin protease.
ATE228760T1 (de) Thrombininhibitoren
NO20003814L (no) Trombininhibitorer
BG100248A (bg) Инхибитори на скваленсинтетаза
DE69731664D1 (de) Thrombininhibitoren
ATE227571T1 (de) Thrombin inhibitoren
YU48719B (sh) Lizin so 6-hloro-5-fluoro-3-(2-tenoil)-2-oksindol-1-karboksamida
ITMI930102A0 (it) Inibitori della trombina

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties